By Dr. Quoc Dang, DO — Medical Director, WeightLossPills.com

Almost every week, I hear a version of the same question. Someone describes their history with weight — years of trying, modest results, gradual regain — and then asks, with a mixture of hope and hesitation: “Do you think medication could help me?”

It is one of the most important questions in obesity medicine, and the answer requires more than a quick yes or no. The landscape of weight loss medication has changed significantly in recent years. The options are more effective than anything we have had before. But they are not right for everyone, and starting treatment without understanding the full picture rarely leads to the best outcomes.

Here is how I think through candidacy in my own practice.

The Clinical Starting Point: BMI and Comorbidities

From a purely clinical standpoint, the FDA-approved thresholds for weight loss medication are a BMI of 30 or higher, or a BMI of 27 or higher in the presence of at least one weight-related condition — such as type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, or cardiovascular disease.

In practice, however, I rarely think about BMI in isolation. BMI is a blunt instrument. A BMI of 29 with significant insulin resistance, fatty liver disease, and a family history of early heart disease is a very different clinical picture than a BMI of 34 with no metabolic complications. I look at the whole picture: metabolic markers, family history, the degree to which excess weight is affecting function and quality of life, and what the patient has already tried.

One of my patients, a 46-year-old named Thomas, came in with a BMI just under 30. Technically he fell below the standard threshold. But his hemoglobin A1C was creeping toward pre-diabetic range, his triglycerides were elevated, and he had been unable to sustain weight loss through diet and exercise despite two serious attempts over the prior three years. We started treatment. A year later, his metabolic markers had fully normalized.

Who Benefits Most

Based on what the research shows and what I see clinically, certain patient profiles tend to get the most from weight loss medication.

Patients with strong biological drivers of weight gain tend to respond especially well. If someone describes feeling hungry most of the time regardless of how much they eat, difficulty feeling full, or intense cravings that feel physiological rather than psychological, those are signs that GLP-1 medications in particular are likely to address the root mechanism. These medications work by mimicking hormones that regulate hunger and satiety — hormones that are often dysregulated in people with obesity.

Patients with obesity-related health conditions stand to gain from treatment in ways that extend well beyond weight alone. The clinical data now shows that semaglutide reduces major cardiovascular events by 20% in high-risk patients. Tirzepatide has demonstrated dramatic improvements in blood sugar and insulin sensitivity. Fatty liver disease, sleep apnea, and joint stress all improve with meaningful weight loss. For patients already managing these conditions, medication is not cosmetic — it is disease management.

Patients who have tried lifestyle intervention seriously and reached a ceiling are also strong candidates. I am careful not to minimize the role of diet and exercise — they matter, they are foundational, and no medication works optimally without them. But for many patients, biology eventually limits how far lifestyle change alone can take them. When someone has genuinely done the work and plateaued, medication is a legitimate next step, not a shortcut.

Who Should Proceed Carefully — or Not at All

There are patients for whom weight loss medication is contraindicated or requires careful evaluation.

GLP-1 receptor agonists — the class that includes semaglutide and tirzepatide — carry a contraindication for patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). If you have that history, these medications are not appropriate for you.

Patients with a history of pancreatitis require a thoughtful risk-benefit conversation. There is an association between GLP-1 medications and acute pancreatitis — the absolute risk is low, but it is not zero, and patients with prior episodes of pancreatitis should proceed only with careful medical supervision.

Pregnancy is an absolute contraindication. Women of childbearing age need to understand that these medications are not safe during pregnancy and that appropriate contraception is essential while on treatment.

For patients with eating disorder history — particularly restrictive or purging-type disorders — I approach medication very carefully and always in coordination with a therapist who specializes in eating psychology. The appetite suppression from these medications can sometimes reinforce restrictive patterns in patients who are vulnerable to them.

The Psychological Readiness Question

Something I discuss with every patient that does not appear in any clinical guideline is psychological readiness. Starting weight loss medication is not just a physical undertaking. It changes your relationship with food, sometimes dramatically. The food noise that has occupied mental space for years goes quiet. Foods you used to crave become less appealing. Social eating feels different.

For most patients, these changes are ultimately positive. But they can be disorienting at first. Patients who come in expecting the medication to do all the work tend to do less well than patients who understand that the medication creates an opportunity — and that they still need to show up with intentional eating, adequate protein, and regular physical activity.

“I thought it was just going to suppress my appetite and the weight would fall off,” one of my patients told me in a follow-up appointment three months after starting treatment. “What I didn’t expect was having to actually think about whether I was eating enough protein every day. It made me more conscious of food, not less.” She had lost 21 pounds in that period and was on track. But she was right — the medication is a tool, and tools require skill to use well.

Practical Steps Before Starting

If you are considering weight loss medication, there are a few things worth doing before your first appointment.

Get a baseline metabolic panel. Fasting glucose, hemoglobin A1C, lipids, thyroid function, and a complete metabolic panel give your physician important context and establish a baseline for tracking improvement over time.

Bring a clear medication list. Some medications interact with GLP-1 agents, and others — particularly diabetes medications like sulfonylureas — may need to be adjusted as your blood sugar improves on treatment.

Be honest about your history. The most useful first appointments are the ones where patients describe what they have genuinely tried, what worked, what did not, and what their relationship with food and exercise has looked like over time. That history is diagnostic. It helps me choose the right medication and anticipate what challenges are likely.

Understand the commitment. Most patients who do well on these medications stay on them long-term. This is not a six-month course. For appropriately selected patients, it is ongoing disease management — and that is worth factoring into both your medical and financial planning.

Choosing the Right Medication

There is now a meaningful range of FDA-approved options, and they are not interchangeable. Tirzepatide (Zepbound) and semaglutide (Wegovy) are currently the most effective options available, with tirzepatide showing higher average weight loss in head-to-head comparisons. But efficacy is only part of the picture — side effect profiles differ, dosing schedules differ, and individual response varies.

Some patients do significantly better on one medication than another. If your first choice does not produce the results you hoped for, or if side effects are difficult to manage, that is worth discussing with your physician. There is no reason to discontinue treatment simply because the first option was not ideal.

If you are at the research stage — trying to understand what the different weight loss pills look like, how they work, and what to expect from each — getting that context before your first medical appointment puts you in a much better position to have a productive conversation and make an informed decision.

The Bottom Line

Weight loss medication is not for everyone. But for the patients who are well-selected — those with a clear metabolic rationale, who have tried lifestyle intervention seriously, who understand what treatment involves, and who are ready to engage with the full process — the results can be genuinely transformative.

The most important step is an honest, thorough evaluation with a physician who takes obesity medicine seriously. Not a quick prescription visit, but a real conversation about your history, your health, and what a treatment plan that serves your long-term wellbeing looks like. That conversation is where good outcomes begin.

 

Dr. Quoc Dang, DO, is a board-certified physician and Medical Director at WeightLossPills.com, where he specializes in medically supervised weight management and GLP-1 therapy.